Company intelligence / Profile preview

Yangzhou Liberty Pharmaceutical

Yangzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Yangzhou Liberty Pharmaceutical is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates based in Yangzhou, China. Established in 2004, the company focuses on the production of high-quality small molecule drugs, particularly for central nervous system disorders. Its flagship products include Gabapentin and Pregabalin, for which it maintains international regulatory compliance and GMP certifications. The company operates as a key supplier in the global pharmaceutical supply chain, providing chemical synthesis and manufacturing services to international partners.

Therapeutic areas: RheumatologyNeurology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Yangzhou Liberty Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangzhou Liberty Pharmaceutical.

Explore the full profile